Bloodstream Infections in Pediatric Cancer Patients
Author Information
Author(s): Murshed Ibrahim Ahmed Saleh, Zhao Lizhen, Zhang Wenzhi, Yin Yuhong, Li Ying, Peng Yun, Chen Hongbo, Wu Xiaoyan
Primary Institution: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Hypothesis
This study aims to investigate the prevalence of specific pathogenic microorganisms and their susceptibility to antimicrobial therapy in pediatric patients with onco-hematological disorders.
Conclusion
The study highlights the critical need for vigilant monitoring and customized infection management strategies to enhance patient outcomes across chemotherapy phases and HSCT.
Supporting Evidence
- Bloodstream infections were a major cause of morbidity and mortality in pediatric onco-hematological patients.
- Gram-positive infections were the most frequent, accounting for 58.4% of cases.
- Neutropenic patients were particularly vulnerable, with 88.3% of infections occurring in this group during the induction phase of chemotherapy.
- Staphylococcus epidermidis was the most common pathogen identified in bloodstream infections.
Takeaway
Kids with cancer can get really sick from infections in their blood, especially when they're getting treatment. It's important to watch them closely and give the right medicines to help them feel better.
Methodology
The study conducted a retrospective analysis of 202 bloodstream infection episodes in pediatric patients admitted to a single center over four years, focusing on demographics, clinical characteristics, and pathogen susceptibility.
Limitations
The study's retrospective nature, potential biases in data collection, and single-center design may limit the generalizability of the findings.
Participant Demographics
The cohort consisted of 90 males (62.0%) and 55 females (37.9%) with a median age of 6.5 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website